Latest In: Hyasynth Biologicals

Image of Canadian cash

Organigram ups investment in cannabinoid firm Hyasynth by CA$2.5 million

Canadian cannabis producer Organigram increased its investment in cannabinoid biosynthesis company Hyasynth Biologicals, the companies announced.

News January 3

Weekly Deal Watch: Cannabis investing and M&A highlights (as of Sept. 14, 2018)

This weekly series from Marijuana Business Daily and Viridian Capital Advisors provides the latest data on cannabis investment activity and…

News September 19

Second US cannabis company uplisted to NYSE to begin trading Tuesday

Image of DEA agent badge

Why cannabis businesses need to apply for DEA registration now – and why states must help

Image of a partially open bank vault door with a glowing light emanating from within

Bipartisan lawmakers reintroduce SAFER Banking on eve of marijuana rescheduling hearings

Image of Miguel Martin

How Aurora Cannabis plans to enter the US market

Image of DEA Chief Administrative Law Judge John Mulrooney II overseeing Monday's marijuana rescheduling hearing

What to expect from the DEA marijuana rescheduling hearing

Macro image of a cannabis bud

Cannabis loyalty isn’t built on THC, it’s built on trust

1

Image of a "For Lease" sign in front of a vacant business space

Green Life Business Group brokers the cannabis industry’s biggest deals

The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator

The Medical Card Has a New Argument

Leveling the Legal Playing Field

Hemp’s Regulatory Reckoning: A Patchwork States Can’t Sustain